Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Tue 22 Sep 2009, 8:30 PSV - PSV Holdings Limited - Acquisition of Cryoshield (Pty) Limited
PSV
PSV                                                                             
PSV - PSV Holdings Limited - Acquisition of Cryoshield (Pty) Limited            
PSV HOLDINGS LIMITED                                                            
(Incorporated in the Republic of South Africa)                                  
(Registration number 1988/004365/06)                                            
JSE code: PSV                                                                   
ISIN: ZAE000078705                                                              
("PSV" or "the company")                                                        
ACQUISITION OF CRYOSHIELD (PTY) LIMITED                                         
1    INTRODUCTION                                                               
    Shareholders are advised that PSV has entered into an agreement with        
    William John Winterton in terms of which PSV will acquire the entire issued 
share capital (including any shareholder`s claims) in Cryoshield (Pty)      
    Limited ("Cryoshield") on the terms and conditions set out below ("the      
    transaction").                                                              
    Warranties and indemnities as are normal in transactions of this nature     
have been provided for in the agreement.                                    
2    BACKGROUND INFORMATION                                                     
    PSV is an industrial engineering holding company which comprises three      
    operating business segments in South Africa and Africa:                     
-    pumps, spares and valves;                                              
    -    engineering linings and general industrial supplies; and               
    -    specialised services - comprising petrochemical and cryogenics.        
    Cryoshield is South Africa`s leading manufacturer of Cryogenic process      
equipment. Established in 1986 by John Winterton, Cryoshield supplies,      
    designs and manufactures prototype process control equipment to the South   
    African gas industries.                                                     
    Cryoshield has been manufacturing large capacity, new generation, cryogenic 
freezing equipment since 1987. This process requires specialised            
    fabricating techniques in stainless steel. Cryoshield is renowned for its   
    technical ability in vacuum and temperature controlled cryogenic processes  
    and has produced equipment ranging from vacuum furnaces, working at 2 500   
degrees Celsius, to low temperature systems, working at minus 270 degrees   
    Celsius.                                                                    
    Cryoshield`s products include:                                              
    -    cryogenic food freezing equipment;                                     
-    cryogenic dosing systems;                                              
    -    custom designed cryogenic gas systems;                                 
    -    transformer oil purification systems;                                  
    -    cryogenic pressure vessels and heat exchangers; and                    
-    gas phase transformer core dehydration system.                         
3    RATIONALE FOR THE TRANSACTION                                              
    The transaction will add critical mass, advanced technologies and new       
    clients to the specialised services subsidiaries within PSV. This segment   
already houses Rand Air and Gas Installations, which designs and produces   
    storage vessels and distribution equipment (road tankers) for the cryogenic 
    industry. The businesses will be combined into a comprehensive cryogenic    
    service offering to the market.                                             
The directors of PSV believe that the transaction will make it the leading  
    supplier of cryogenic technology in South Africa. Cryoshield has a number   
    of long-term contracts from which PSV will also benefit.                    
4.   PURCHASE CONSIDERATION AND PAYMENT TERMS                                   
The purchase consideration is R8 million in cash payable as follows:        
    -    the lower of R2 million or the tangible net asset value as at 28       
         February 2009 ("TNAV"), payable on the effective date;                 
    -    the sum of R4 million plus 66.6% of the amount (if any) by which the   
TNAV is less than R2 million, payable on 31 July 2010; and             
    -    the sum of R2 million plus 33.3% of the amount (if any) by which the   
         TNAV is less than R2 million, payable on 31 July 2011.                 
5.   CONDITIONS PRECEDENT                                                       
The transaction is subject only to the completion of a satisfactory due     
    diligence investigation by PSV on Cryoshield.                               
6.   EFFECTIVE DATE                                                             
    The transaction will become effective on the first business day of the      
month immediately succeeding that during which all of the conditions        
    precedent shall have become fulfilled, or waived as the case may be.        
7.   FINANCIAL EFFECTS                                                          
    The unaudited pro forma financial effects set out below are provided for    
illustrative purposes only to assist shareholders to assess the impact of   
    the transaction on the earnings per share ("EPS"), headline earnings per    
    share ("HEPS"), diluted earnings per share ("DEPS"), diluted headline       
    earnings per share ("DHEPS"), net asset value per share ("NAVPS") and       
tangible net asset value per share ("TNAVPS") of PSV. These unaudited pro   
    forma financial effects have been disclosed in terms of the JSE Listings    
    Requirements and because of their nature may not give a fair presentation   
    of the PSV`s results and financial position after the transaction. The      
unaudited pro forma financial effects are the responsibility of the         
    directors of PSV and are presented in a manner consistent with the          
    accounting policies adopted by PSV.                                         
    The pro forma effect of the transaction on EPS, HEPS, DEPS, DHEPS, and      
NAVPS is insignificant (less than 3%). TNAVPS of 34.1 cents as calculated   
    from PSV`s audited results for the year ended 28 February 2009 decrease by  
    7.3% to 31.6 cents on a pro forma basis based on the following assumptions  
    and information:                                                            
- the transaction was effective 28 February 2009;                           
    - the purchase price of R8 million was paid on 28 February 2009 in the      
    manner described in note 2 above;                                           
    - transaction costs have been ignored due to immateriality; and             
- the revaluations and allocations that may arise from the application of   
    IFRS 3 (Business Combinations) have not been made as this will only be      
    finalised in due course. The pro forma financial information has thus been  
    prepared on the basis that the excess of the purchase price over the net    
asset value of Cryoshield of R2 million will comprise goodwill of R6        
    million.                                                                    
7.   SERVICE AND RESTRAINT AGREEMENT                                            
    A written service, confidentiality and restraint agreement has been         
concluded between Mr Winterton and PSV.                                     
8.   CLASSIFICATION OF THE TRANSACTION                                          
    The transaction is classified as a Category 2 transaction in terms of the   
    Listings Requirements of the JSE Limited.                                   
Johannesburg                                                                    
22 September 2009                                                               
Corporate and Designated Adviser                                                
Vunani Corporate Finance                                                        
Date: 22/09/2009 08:30:01 Produced by the JSE SENS Department.                  
The SENS service is an information dissemination service administered by the    
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or            
implicitly, represent, warrant or in any way guarantee the truth, accuracy or   
completeness of the information published on SENS. The JSE, their officers,     
employees and agents accept no liability for (or in respect of) any direct,     
indirect, incidental or consequential loss or damage of any kind or nature,     
howsoever arising, from the use of SENS or the use of, or reliance on,          
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: